Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Early identification of cardiovascular risk using genomics and proteomics.
Kullo IJ, Cooper LT. Kullo IJ, et al. Nat Rev Cardiol. 2010 Jun;7(6):309-17. doi: 10.1038/nrcardio.2010.53. Epub 2010 May 4. Nat Rev Cardiol. 2010. PMID: 20440292 Free PMC article. Review.
With the recent advances in genomics and proteomics, many new risk factors with small-to-moderate effects are likely to be identified. ...With a multimarker approach, it may also be possible to identify alterations in pathways involved in atherogenesis …
With the recent advances in genomics and proteomics, many new risk factors with small-to-moderate effects are li …
Early Diagnosis and Prediction of Anticancer Drug-induced Cardiotoxicity: From Cardiac Imaging to "Omics" Technologies.
Madonna R. Madonna R. Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):576-582. doi: 10.1016/j.rec.2017.02.001. Epub 2017 Feb 27. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28246019 Review. English, Spanish.
These patients often have no prior manifestation of disease. There is therefore a need for accurate identification of individuals at risk of such events before the appearance of clinical manifestations. The present article aims to provide an overview of cardi …
These patients often have no prior manifestation of disease. There is therefore a need for accurate identification of individu …
The role of gene expression profiling in early-stage non-small cell lung cancer.
Shao W, Wang D, He J. Shao W, et al. J Thorac Dis. 2010 Jun;2(2):89-99. J Thorac Dis. 2010. PMID: 22263026 Free PMC article.
For patients with identical clinical-pathological characteristics or the same stage of lung cancer, great uncertainties remain regarding how some patients will be cured while other patients will have cancer recurrence, metastasis, or death after surgical resection. Identificat
For patients with identical clinical-pathological characteristics or the same stage of lung cancer, great uncertainties remain regarding how …